Trending...
- Purple Heart Recipient Honored by Hall of Fame Son In Viral Tribute Sparking National Conversation on Service Fatherhood, Healing and Legacy
- Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract
- VENUS Goes Live on CATEX Exchange As UK Financial Ltd Activates The Premier Division Of The Maya Meme's League
Today, Governor Roy Cooper announced that Audentes Therapeutics, a genetic medicines company, will create 209 new jobs in Lee County, investing $109 million to locate a manufacturing facility in Sanford.
"With our powerhouse research centers and highly-skilled workforce, biotech pioneers recognize North Carolina's role as a leader in the life sciences," said Governor Cooper. "Lee County is a perfect fit for Audentes as they seek to become a global leader in genetic medicines."
An Astellas company, Audentes Therapeutics focuses on developing and commercializing innovative genetic medicines that can offer transformative benefits to patients. Audentes will develop a 135,000 square foot, state-of-the-art, large-scale gene therapy manufacturing facility in Sanford. The initial phase of the capital investment is planned to occur over approximately 18 months, with the plant expected to become operational in 2021. The remaining investment will take place over two additional planned expansion phases.
"Our investment in internal large-scale manufacturing has always been a cornerstone of our strategy to develop and ultimately deliver our important genetic medicines to patients as rapidly as possible. This new facility in Sanford will support the next phase of our growth as we establish a robust, global supply chain and expand our therapeutic and geographic scope as a part of the Astellas group of companies," stated Natalie Holles, President and Chief Executive Officer of Audentes. "We are excited to join the vibrant biopharmaceutical research and manufacturing community that the state of North Carolina has established."
More on ncarol.com
"Audentes Therapeutics is joining one of the nation's top life science clusters," said North Carolina Commerce Secretary Anthony M. Copeland. "North Carolina has the largest biomanufacturing workforce in the nation and a growing concentration of gene therapy scientists, researchers and workers."
The North Carolina Department of Commerce led the state's support for the company's decision.
The average for all new positions could reach up to $83,900. The current average annual wage in Lee County of $41,784.
Audentes' project in North Carolina will be facilitated, in part, by a Job Development Investment Grant (JDIG) approved by the state's Economic Investment Committee earlier today. Over the course of the 12-year term of this grant, the project is estimated to grow the state's economy by nearly $1.4 billion. Using a formula that takes into account the new tax revenues generated by the 209 new jobs, the JDIG agreement authorizes the potential reimbursement to the company of up to $3,725,100, spread over 12 years. State payments only occur following performance verification by the departments of Commerce and Revenue that the company has met its incremental job creation and investment targets. JDIG projects result in positive net tax revenue to the state treasury, even after taking into consideration the grant's reimbursement payments to a given company.
More on ncarol.com
Because Audentes chose to locate in Lee County, classified by the state's economic tier system as Tier 2, the company's JDIG agreement also calls for moving as much as $414,000 into the state's Industrial Development Fund – Utility Account. The Utility Account helps rural communities finance necessary infrastructure upgrades to attract future business. Even when new jobs are created in a Tier 2 county such as Lee, the new tax revenue generated through JDIG grants helps more economically challenged communities elsewhere in the state. More information on the state's economic tier designations is available here.
"This is an exciting day for Lee County and the City of Sanford because this business is an important part of the biotechnology industry, creating hundreds of jobs and contributing millions of dollars to our local economy," said N.C. Senator Jim Burgin.
"Audentes' new jobs and investment are great wins for the entire state," said N.C. Representative John Sauls. "North Carolina has a strong pipeline of biopharmaceutical talent and a business climate to support their future growth and success."
In addition to N.C. Commerce and the Economic Development Partnership of North Carolina, other key partners in the project include the North Carolina General Assembly, North Carolina Community College System, Lee County, Sanford Area Growth Alliance, City of Sanford, and North Carolina Biotechnology Center.
"With our powerhouse research centers and highly-skilled workforce, biotech pioneers recognize North Carolina's role as a leader in the life sciences," said Governor Cooper. "Lee County is a perfect fit for Audentes as they seek to become a global leader in genetic medicines."
An Astellas company, Audentes Therapeutics focuses on developing and commercializing innovative genetic medicines that can offer transformative benefits to patients. Audentes will develop a 135,000 square foot, state-of-the-art, large-scale gene therapy manufacturing facility in Sanford. The initial phase of the capital investment is planned to occur over approximately 18 months, with the plant expected to become operational in 2021. The remaining investment will take place over two additional planned expansion phases.
"Our investment in internal large-scale manufacturing has always been a cornerstone of our strategy to develop and ultimately deliver our important genetic medicines to patients as rapidly as possible. This new facility in Sanford will support the next phase of our growth as we establish a robust, global supply chain and expand our therapeutic and geographic scope as a part of the Astellas group of companies," stated Natalie Holles, President and Chief Executive Officer of Audentes. "We are excited to join the vibrant biopharmaceutical research and manufacturing community that the state of North Carolina has established."
More on ncarol.com
- National Expansion Ignited Across Amazon $AMZN, Chewy $CHWY & Walmart $WMT: NDT Pharmaceuticals, Inc. (Stock Symbol: NDTP) $NDTP
- Distributed Social Media - Own Your Content
- Tarrytown Expocare Pharmacy Announces Strategic Leadership Appointments to Accelerate Growth and Innovation
- New Environmental Thriller "The Star Thrower" Reimagines a Classic Lesson in Individual Impact
- Summit Appoints Javier Cabeza as Data, AI, and Analytics Practice Lead
"Audentes Therapeutics is joining one of the nation's top life science clusters," said North Carolina Commerce Secretary Anthony M. Copeland. "North Carolina has the largest biomanufacturing workforce in the nation and a growing concentration of gene therapy scientists, researchers and workers."
The North Carolina Department of Commerce led the state's support for the company's decision.
The average for all new positions could reach up to $83,900. The current average annual wage in Lee County of $41,784.
Audentes' project in North Carolina will be facilitated, in part, by a Job Development Investment Grant (JDIG) approved by the state's Economic Investment Committee earlier today. Over the course of the 12-year term of this grant, the project is estimated to grow the state's economy by nearly $1.4 billion. Using a formula that takes into account the new tax revenues generated by the 209 new jobs, the JDIG agreement authorizes the potential reimbursement to the company of up to $3,725,100, spread over 12 years. State payments only occur following performance verification by the departments of Commerce and Revenue that the company has met its incremental job creation and investment targets. JDIG projects result in positive net tax revenue to the state treasury, even after taking into consideration the grant's reimbursement payments to a given company.
More on ncarol.com
- Interview: Why I Sponsored Carson Ware - The Full Story
- March Is Skiing's Smartest Buying Window
- Zeo Health Introduces KidZ Cleanse with Folinic Acid
- Cancun Airport Transportation Expands Fleet Ahead of Record Passenger Growth at Cancun International Airport
- Tobu Group's "T-home Series" of Accommodations in Tokyo Just Opened "T-home KEI."
Because Audentes chose to locate in Lee County, classified by the state's economic tier system as Tier 2, the company's JDIG agreement also calls for moving as much as $414,000 into the state's Industrial Development Fund – Utility Account. The Utility Account helps rural communities finance necessary infrastructure upgrades to attract future business. Even when new jobs are created in a Tier 2 county such as Lee, the new tax revenue generated through JDIG grants helps more economically challenged communities elsewhere in the state. More information on the state's economic tier designations is available here.
"This is an exciting day for Lee County and the City of Sanford because this business is an important part of the biotechnology industry, creating hundreds of jobs and contributing millions of dollars to our local economy," said N.C. Senator Jim Burgin.
"Audentes' new jobs and investment are great wins for the entire state," said N.C. Representative John Sauls. "North Carolina has a strong pipeline of biopharmaceutical talent and a business climate to support their future growth and success."
In addition to N.C. Commerce and the Economic Development Partnership of North Carolina, other key partners in the project include the North Carolina General Assembly, North Carolina Community College System, Lee County, Sanford Area Growth Alliance, City of Sanford, and North Carolina Biotechnology Center.
0 Comments
Latest on ncarol.com
- Primeindexer Google indexing platform launched by SEO Danmark APS
- Kaltra Introduces New Downward-Spraying Distribution Technology to Boost Microchannel Evaporator Performance
- Talentica Announces Winners of Multi-Agent Hackathon 2026
- Special Alert: Undervalued Opportunity: IQSTEL (N A S D A Q: IQST) Positioned for Explosive Multi-Year Growth
- Triple-Digit Growth, Strategic N A S D A Q Uplist, Plus A Scalable Healthcare Rollout Model: Stock Symbol: CDIX
- Vesica Health Receives FDA Breakthrough Device Designation for AssureMDx
- Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract
- Cancun All Inclusive is ready for Spring Break 2026 with new Resorts, Exclusive Deals, activities and more!
- 66% of US Bankruptcies Are Medical — So Americans Are Building Businesses That Cover Healthcare Emergencies
- Husband and Wife Release Children's Book and Donate Proceeds to Non-Profit
- Ludex Partners With Certified Trading Card Association (CTCA) To Elevate Standards And Innovation In The Trading Card Industry
- Best Book Publishing Company for Aspiring Authors
- Dr. Nadene Rose Releases Moving Memoir on Faith, Grief, and Divine Presence
- Gigasoft Solves AI's Biggest Charting Code Problem: Hallucinated Property Names
- AKG To Demonstrate New Digital E-catalog Experience Daily At CONEXPO CON/AGG 2026
- ASTI Ignites the Space Economy: Powering SpaceX's NOVI AI Pathfinder with Breakthrough Solar Technology: Ascent Solar Technologies (N A S D A Q: ASTI)
- STEM For Kids Launches Root Protocol™: A Human Bridge for Gen Alpha's Digital Curiosity Crisis
- Hiring has reached a "Digital Stalemate"—Now, an ex-Google recruiter is giving candidates the answers
- 2026 Pre-Season Testing Confirms a Two-Tier Grid as Energy Management Defines Formula 1's New Era
- Platinum Car Audio LLC Focuses on Customer-Driven Vehicle Audio and Electronics Solutions